Jupiter Topco »

Protagonist Therapeutics shares owned by Jupiter Topco

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Jupiter Topco from 13F filings

Historical chart of Jupiter Topco investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Jupiter Topco consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Jupiter Topco

Quarter filed Position value Share count Share price at filing
2026-06-30 $261M 2.1M 122.58

More positions owned by Jupiter Topco

NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Apple (AAPL)
Eli Lilly & Co. (LLY)
Lam Research Corp Com New (LRCX)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Micron Technology (MU)
Kla Corp Com New (KLAC)
Meta Platforms Cl A (META)
Ge Vernova (GEV)
Argenx Se Sponsored Adr (ARGX)
Flex Ord (FLEX)

View all positions for Jupiter Topco

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
UBS Group
Rtw Investments
Vanguard Portfolio Management
Wellington Management Company
State Street Corporation
Henderson Group
Vanguard Capital Management
Johnson & Johnson
Invesco
Jupiter Topco
Geode Capital Management
T. Rowe Price Associates
Woodline Partners

View all funds holding Protagonist Therapeutics